Latest News
You need an actual strategy to avoid falling behind.
Via The Motley Fool · September 20, 2026
Four quarters at the memory maker's guided pace would surpass what the software giant earned in its record fiscal 2026. Whether the pace holds hinges on memory prices.
Via The Motley Fool · September 20, 2026
One is burning cash to scale a novel battery technology. The other generates $3.7 billion in free cash flow annually.
Via The Motley Fool · September 20, 2026
Bill Ackman sold Alphabet and bought Meta Platforms during Q2.
Via The Motley Fool · September 20, 2026
Ethereum's days of outrageous upside volatility are probably not coming back, but that shouldn't dissuade anyone from buying it.
Via The Motley Fool · September 20, 2026
Lexicon Pharmaceuticals (NASDAQ:LXRX) said it has completed enrollment in its Phase III SONATA-HCM study of sotagliflozin in hypertrophic cardiomyopathy, with topline data expected in the first quarter of 2027.
Speaking at the H.C. Wainwright 28th Annual Global Investment Conference, Chief Executiv
Via MarketBeat · September 20, 2026
The Vanguard Total Bond Market ETF is the largest bond-focused ETF.
Via The Motley Fool · September 20, 2026
Apple is on track to do something great that it hasn't done since 2012.
Via The Motley Fool · September 20, 2026
Nvidia’s chief offers a new clue about future sales.
Via The Motley Fool · September 20, 2026
Choosing a web design company is a big decision for any business in Qatar. Your website is often the first place a customer meets your brand, so the team y
Via Talk Markets · September 20, 2026
Utilities are usually seen as low-risk bets, but due to its California footprint, risk abounds with PG&E.
Via The Motley Fool · September 20, 2026
Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.
Via The Motley Fool · September 20, 2026
Alnylam Pharmaceuticals (NASDAQ:ALNY) highlighted continued momentum for its AMVUTTRA treatment in transthyretin-mediated cardiomyopathy, while outlining a pipeline of upcoming clinical catalysts and discussing changes in the market that prompted a revision to its 2026 TTR franchise revenue outlook.
Via MarketBeat · September 20, 2026
Investors can add the fast-growing AI lab to their portfolios indirectly by picking up shares of Zoom Communications.
Via The Motley Fool · September 20, 2026
CAKHIATV là nền tảng cập nhật bóng đá trực tuyến với trải nghiệm xem tiện lợi, hình ảnh ổn định và nội dung đa dạng. Người dùng có thể theo dõi lịch thi đấ
Via Talk Markets · September 20, 2026
These fast-growing bank stocks offer incredible opportunities for investors.
Via The Motley Fool · September 20, 2026
Memory and silicon photonics shortages run through 2030, and Micron, Coherent and Tower Semiconductor sit on the supply side of an AI buildout under strain.
Via MarketBeat · September 20, 2026
After this year's brutal sell-off, Joby looks poised for a rebound.
Via The Motley Fool · September 20, 2026

The Bank of Japan voted 7–2 to lift its policy rate from 1.0% to 1.25%, effective September 24, as policymakers weighed rising underlying inflation against
Via Talk Markets · September 20, 2026
Significant optimism is already baked into SpaceX stock.
Via The Motley Fool · September 20, 2026
Caterpillar is in an excellent position as hyperscalers rush to spend capital on their AI build-outs.
Via The Motley Fool · September 20, 2026
The S&P 500 hasn't been this expensive since the dot-com internet bubble in the late 1990s.
Via The Motley Fool · September 20, 2026
IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare Conference, while reaffirming confidence in its long-term growth framework despite continued pressure
Via MarketBeat · September 20, 2026
While gold trades roughly flat YTD, Coeur Mining, Alamos Gold, and Wheaton Precious Metals have outperformed, boosted by strong earnings, free cash flow, and rising dividends.
Via MarketBeat · September 20, 2026
The leading network airline is a very different business from what it was a decade ago, and it might be time for the market to rerate its stock.
Via The Motley Fool · September 20, 2026
